Article Details

INVO Bioscience (NASDAQ:INVO) Upgraded to “Buy” by Zacks Investment Research

Retrieved on: 2022-04-16 17:42:54

Tags for this article:

Click the tags to see associated articles and topics

INVO Bioscience (NASDAQ:INVO) Upgraded to “Buy” by Zacks Investment Research. View article details on hiswai:

Excerpt

INVO Bioscience, Inc, a medical device company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a patented ...

Article found on: www.defenseworld.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up